Cumulative evidence matters in the study of vaccine-induced iatrogenic disease and death

by James Lyons-Weiler, PhD, Popular Rationalism, ©2026

(Oct. 20, 2026) — Science loses its cumulative force when every new study must establish, by itself, every link between an exposure and a disease. A computational analysis can identify a candidate immune target. An antibody experiment can test recognition. A longitudinal study can establish when an abnormality appeared. A functional experiment can show how that abnormality disrupts physiology. A clinical investigation can connect the disruption to injury and death. Each contribution has a limited task. Together, well-designed studies can support an explanation that no single experiment could establish.

A study can fall short of establishing causation on its own while materially changing the causal assessment. Repeatedly stating the first fact and ignoring the second resets the evidence to zero.

That is not how science works. It induces an error of argument from ignorance, among others.

That error matters in the study of iatrogenic disease: illness caused by medical intervention. Vaccine safety requires an evidentiary method capable of detecting injury, investigating its causes and informing prevention. The method must also distinguish a plausible mechanism from a demonstrated mechanism, and an individual clinical syndrome from its frequency in an exposed population. Those distinctions allow knowledge to accumulate.

The question is what a new result adds to everything already known, including findings that challenge the proposed explanation. Is it replication? Is it validation? Is it corroboration? These depend on context of the scientific arena in which a study sets. An assessment that considers each publication in isolation cannot answer questions – and science takes on the glean of eternal theorizing and hypothesis-generation. An assessment that merely counts supportive publications cannot answer it either.

This article explores the use of cumulative prior knowledge and evidence in studies of the pathophysiology of vaccines using pathogenic priming as an example.

A prediction creates a record that can be tested

In April 2020, I published an analysis of pathogenic priming: the possibility that immune recognition of viral components resembling human proteins could contribute to harmful responses against the host. The peer-reviewed study identified candidate human proteins that would be targeted if the putative auto-reactogenic epitopes identified were correctly identified and characterized and reported which connected tissues and biological pathways that would be effected. It also raised a prevention objective for vaccine development: investigate potentially harmful immune recognition before selecting components for use in people. [1]

The original table matters because it preserves what the analysis actually hypothesized. FSTL1 appeared among the spike-associated candidates. The titin entry, with its heart and skeletal-muscle association, belonged to a different viral protein, the 3C-like proteinase. Aquaporin-4 and thyroid peroxidase were not named matches in that table. These details enable any claim of subsequent confirmation. The analysis supplied computational candidates; it did not measure patient autoimmunity or establish a calibrated predictive success rate. [1]

---

Read the rest here.